跳至主要内容
临床试验/IRCT20140528017891N8
IRCT20140528017891N8已完成3 期

Evaluation of the efficacy and safety of cord-derived mesenchymal stem cell transplantation in the treatment of COVID-19

MOM research and innovation center0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 95 years(—)
性别
All

入选标准

  • Patients in acute phase
  • Laboratory confirmation of SARS-COV-2 infection
  • Pneumonia confirmed by chest x-ray or tomography
  • Respiratory rate> 30 times / minute
  • Oxygen Saturation less than 93%
  • Arterial oxygen partial pressure (Pao2) /oxygen inhalation(Fio2) less than 300 mmHg
  • No history of tumor or malignant disease

排除标准

  • Pregnant patient with a positive pregnancy test or during lactation or who is planning to become pregnant during the study
  • The definitive history of acquired or inherited immune deficiency diseases
  • The definitive psychotic illness A history of serious mental illness or a history of suicide
  • The use of NG tube
  • Creatinine greater than 1.7 or hepatic enzymes three times normal or white blood cell count lower than 3000 and hemoglobin less than 10
  • Co-infection of human immunodeficiency viruses, Hepatitis B, Hepatitis C and Human T-lymphotropic virus

研究者

发起方
MOM research and innovation center

相似试验